IL-2-loaded Polypeptide Nanoparticles for Enhanced Anti-cancer Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IL-2-loaded Polypeptide Nanoparticles for Enhanced Anti-cancer Immunotherapy

Published:2023-01-16 Issue:7 Volume:41 Page:1059-1068
ISSN:0256-7679
Container-title:Chinese Journal of Polymer Science
language:en
Short-container-title:Chin J Polym Sci

Author:

Wang Xiao-Shuang,Zheng Zhao-Shi,Zheng Meng-Fei,Wang Di,Zhang Hong-Lei,Zhang Zhen-Qian,Liu Zhi-Lin,Tang Zhao-Hui,Han Xue-Mei

Publisher

Springer Science and Business Media LLC

Subject

Polymers and Plastics,Organic Chemistry,General Chemical Engineering

Link

https://link.springer.com/content/pdf/10.1007/s10118-023-2898-2.pdf

Reference36 articles.

1. Morgan, D. A.; Ruscetti, F. W.; Gallo, R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 1976, 193, 1007–1008.

2. Liao, W.; Lin, J. X.; Leonard, W. J. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 2013, 38, 13–25.

3. Hernandez, R.; Poder, J.; LaPorte, K. M.; Malek, T. R. Engineering IL-2 for immunotherapy of autoimmunity and cancer. Nat. Rev. Immunol. 2022, 22, 614–628.

4. Abbas, A. K.; Trotta, E.; Simeonov, D. R.; Marson, A.; Bluestone, J. A. Revisiting IL-2: biology and therapeutic prospects. Sci. Immunol. 2018, 3, eaat1482.

5. Rosenberg, S. A.; Lotze, M. T.; Muul, L. M.; Chang, A. E.; Avis, F. P.; Leitman, S.; Linehan, W. M.; Robertson, C. N.; Lee, R. E.; Rubin, J. T. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N. Engl. J. Med. 1987, 316, 889–897.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly(phenylalanine) and poly(3,4-dihydroxy-L-phenylalanine): Promising biomedical materials for building stimuli-responsive nanocarriers;Journal of Controlled Release;2024-08

2. Development of a bacteria-nanosapper for the active delivery of ZIF-8 particles containing therapeutic genes for cancer immune therapy;Acta Pharmaceutica Sinica B;2024-07

3. Emerging cytokine delivery with nanomedicine for brain cancer treatment;Expert Opinion on Drug Delivery;2024-04-02

4. The combination of IL-2 nanoparticles and Palbociclib enhances the anti-tumor immune response for colon cancer therapy;Frontiers in Immunology;2024-01-30

5. Polymeric Nanomedicines for Controlled Release of Sulfur Dioxide;ACTA POLYM SIN;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3